118. Hasskarl J, Velupillai P, Piboonniyom S, Grace M, Münger K: Long-term maintenance of human keratinocytes in vitro, J. Invest. Dermatol 2005;124:475-8. 119. DeMasi J, Huh K-W, Nakatani Y, Münger K, Howley PM: Bovine papillomavirus E7 transformation correlates with cellular p600 protein binding, Proc. Natl. Acad. Sci. USA 2005;102:11486-91. 120. Huh K-W, DeMasi J, Ogawa H, Nakatani Y, Howley PM, Münger K: Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600, Proc. Natl. Acad. Sci. USA 2005;102:11492-7. 121. Wise-Draper TM, Allen HV, Thobe MN, Jones EE, Habash KB, Münger K, Wells SI: The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk HPV E7, J. Virol. 2005;79:14309-17. 122. Georgakoudi I, Levitt J, Baldwin A, Papadakis A, Münger K. Intrinsic fluorescence changes associated with apoptosis of human epithelial keratinocytes. Gynecol Oncol 2005;99:S54-7 123. Münger K, Hayakawa H, Nguyen CL, Melquiot NV, Duensing A, Duensing S. Viral carcinogenesis and genomic instability: In “Cancer, Cell Structures, Carcinogens and Genomic Instability” EXS volume 96, Birkhauser Boston, 2005 pp 179-99 124. Hasskarl J, Velupillai P, Münger K: Increased in vitro life span of primary human keratinocytes correlates with decreased migration, J. Invest. Dermatol 2006;126:1179-81. 125. Baldwin A, Huh KW, Münger K: The HPV E7 Oncoprotein Dysregulates Steroid Receptor Coactivator-1 Localization and Function, J. Virol. 2006;80:6669-77. 126. Levitt J, Baldwin A, Papadakis A, Münger K, Georgakoudi I: Intrinsic fluorescence changes associated with apoptosis of primary human epithelial cells, J. Biomed. Optics 2006;11:064012. 127. Münger K: American Idol and NIH Grant Review-Redux. Cell 2006;127:661-2. 128. Nakatani Y, Münger K: p600, a novel cellular target of viral transforming proteins to evade apoptosis in neoplastic growth. Jikken Igaku 2006; 24:2943-6 (in Japanese) 129. Miao H, Tallarico JA, Hayakawa H, Münger K, Duffner J, Koehler AN, Schreiber SL, Lewis TA: Ring-opening and ring-closing reactions of a shikimic acid-derived substrate leading to diverse small molecules, J. Comb. Chem 2007;9:245-53 130. Münger K, Howley PM, DiMaio D: Human Papillomavirus E6 and E7 oncogenes: In “The Papillomaviruses” (R Garcea, D DiMaio Eds) Springer New York NY, 2007 pp195-251 131. Nguyen CL, Hayakawa H, Münger K: Activities of human papillomavirus oncoproteins that contribute to genomic instability and carcinogenic progression; In “Human Papillomavirus Gene Regulation and Transformation (B Norrild Ed) Transworld Research Network, Trivandrum, India, 2007 pp139-164. 132. Huh KW, Zhou X, Hayakawa H, Cho J-Y, Libermann TA, Jin J, Harper JW, Munger K: The human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase, which contributes to degradation of the pRB tumor suppressor, J. Virol. 2007;81:9737-47. 133. Mujat C, Greiner C, Baldwin A, Levitt JM, Tian F, Stucenski LA, Hunter M, Kim YL, Backman V, Feld M, Munger K, Georgakoudi I: Endogenous optical biomarkers of normal and human papillomavirus immortalized epithelial cells, Int. J. Cancer 2008;122:363-71. 134. Nguyen CL, Eichwald C, Nibert ML, Münger K: The human papillomavirus Type 16 E7 Oncoprotein Associates with the Centrosomal Component γ-Tubulin, J Virol 2007; 81:13533-44, 2007 135. Levitt JM, Hunter M, Mujat C, McLaughlin-Drubin M, Münger K, Georgakoudi I: Extraction of cellular organization features from intrinsic fluorescence images for disease diagnosis, Opt Lett 2007; 32:3305-7. 136. McLaughlin-Drubin M, Münger K: Viruses Associated with Human Cancer. Biochim Biophys Acta 2008; 1782:127-50. 137. Mangold U, Hayakawa H, Coughlin M, Münger K, Zetter BR: Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification, Oncogene 2008; 27:604-13. 138. Hasskarl J, Stern D, Münger K: Interference of the dominant negative helix-loop-helix protein ID1 with the proteasomal subunit S5A causes centrosomal abnormalities, Oncogene 2008, 27:1657-64. 139. McLaughlin-Drubin M, Münger K: The human papillomavirus type 8 E2 gene encodes a transforming activity that is sufficient for skin tumor formation in transgenic mice (Commentary). J. Invest Dermatol 2008; 128:2142-4 140. McLaughlin-Drubin M, Huh KW, Münger K: The Human Papillomavirus Type 16 E7 Oncoprotein Associates with E2F6, J Virol 2008; 82:8695-705. 141. Nguyen CL, Münger, K: Direct association of the HPV16 E7 oncoprotein with cdk2/cyclin A and cdk2 cyclin E complexes, Virology 2008; 308:21-5 142. Grueneberg DA, Degot S, Pearlberg J, Li W, Joan E. Davies JA, Baldwin A, Endege W, Doench J, Sawyer J, Hu Y, Boyce F, Xian J, Munger K, Harlow E: Kinase Requirements in Human Cells: I Comparing Kinase Requirements Across Various Cell Types. Proc Natl Acad Sci USA 2008;105:16472-7. 143. Baldwin A, Li W, Grace M, Pearlberg J, Harlow E, Münger K, Grueneberg DA: Kinase Requirements in Human Cells: II. Genetic Interaction Screens Identify Kinase Requirements Following HPV16 E7 Expression in Cancer Cells. Proc Natl Acad Sci USA 2008;105:16478-83. 144. Nguyen CL, McLaughlin-Drubin ME, Münger K: Delocalization of the Microtubule Motor Dynein from Mitotic Spindles by the Human Papillomavirus E7 Oncoprotein is Not Sufficient for Induction of Multipolar Mitoses. Cancer Res 2008;68:8715-22 145. Mok SC, Wong K-k, Lu K, Münger K Nagymanyoki Z: Molecular Basis of Gynecologic Diseases. In: “Molecular Pathology-The Molecular Basis of Human Disease” (WB Coleman and GJ Tsongalis, eds) Elsevier-Academic Press, San Diego, 2009, pp 465-88. 146. McLaughlin-Drubin ME, Münger K: The Human Papillomavirus E7 Oncoprotein. Virology 2009; 384: 335-44. 147. Zhou X, Münger K: Expression of the Human Papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivation, Virology 2009; 385:192-7. 148. Nguyen CL, Munger, K: The human papillomavirus E7 protein deregulates mitosis via an association with the Nuclear Mitotic Apparatus Protein-1 (NuMA), J Virol. 2009; 83:1700-7. 149. Zhou X, Spangle JM, Münger K: Expression of a viral oncoprotein in normal human epithelial cells triggers an autophagy related process – is autophagy an “Achilles’ heel” of human cancers? Autophagy 2009; 5:578-9 150. Hellner K, Mar JC, Fang F, Quackenbush J, Münger K: HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition, Virology 2009; 391:57-63. 151. McLaughlin-Drubin M, Münger, K: Oncogenic Activities of Human Papillomaviruses. Virus Res 2009; 143:195-208. 152. Korzeniewski N, Zheng L, Cuevas R, Parry J, Chatterjee P, Anderton B, Duensing A, Münger K, Duensing S: Cullin 1 functions as a centrosomal suppressor of centriole multiplication by regulating Polo-like kinase 4 protein levels. Cancer Res 2009; 69:6668-75. 153. Kamil JP, Hume AJ, Jurak I, Münger K, Kalejta, RF, Coen DM: Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase. Proc Natl Acad Sci USA 2009; 106:16823-28. 154. Baldwin A, Münger K: Molecular Events Associated with Human Papillomavirus-Induced Human Cancers. In: “Viral Oncology: Basic Science and Clinical Applications” (K Khalili and KT Jeang eds) Wiley-Blackwell, Hoboken NJ, 2010, pp 23-55. 155. Nguyen CL, McLaughlin-Drubin ME, Münger K: Human Papillomaviruses and Associated Malignancies. In: “Human Oncogenic Viruses” (B Yen and J Ou, eds) World Scientific Press, Singapore, 2010, pp 137-207 156. Lowy DR, Münger K: Prognostic implications of HPV in oropharyngeal carcinoma, New England J Med 2010; 363: 82-4 157. Baldwin A, Grueneberg DA, Hellner K, Sawyer J, Grace
W, Li W, Harlow E, Munger K: Kinase Requirements in Human Cells: V. Synthetic
lethal interactions between p53 and the protein kinases SGK2 and PAK3, Proc
Natl Acad Sci USA 2010; 107: 12463-8. 158. Spangle JM, Münger K: The human papillomavirus type
16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis, J
Virol 2010; 84(18), 9398-407. 159. Quesnelle K, Grandis J,
Munger K, Posner MR: Head and Neck Cancer. In “Molecular Oncology: Causes of
Cancer and Targets for Treatment” (E. Gelman, C Sawyers and F. Rauscher III,
eds), Cambridge University Press, Cambridge, in press. 160. Zhou X, Münger K: Clld7, a candidate tumor suppressor
on chromosome 13q14, regulates pathways of DNA damage/repair and apoptosis.
Cancer Res, 2010; 70: 9434-43.
161. Duensing S, Darr S, Cuevas
R, Melquiot N, Brickner AG, Duensing A, Münger K: Tripeptidyl peptidase II is
required for c-MYC-induced centriole overduplication and a novel therapeutic
target in c-MYC-associated neoplasms. Genes & Cancer 2010; 1:883-92. 162. McLaughlin-Drubin ME, Crum
C, Münger K: The Human Papillomavirus E7 oncoprotein induces KDM6A and KDM6B
histone demethylase expression and causes epigenetic reprogramming, Proc Natl
Acad Sci U S A. 2011; 108: 2130-5.
163. Hellner K, Münger K: Human papillomaviruses as therapeutic targets in human cancer, J. Clin Oncol 2011, 29: 1785-94. 164. Levitt JM, McLaughlin-Drubin ME, Münger K, Georgakoudi I: Automated biochemical, morphological and organizational assessment of precancerous changes from endogenous two-photon fluorescence images, PLoS ONE 2011, 6: e24765 165. Münger K, Duensing S: Induction of
genomic instability by human papillomavirus oncoproteins. In “Small DNA Tumour
Viruses” (K Gaston ed) Caister Academic Press, Norfolk UK, 2012 239-54.
166. White EA, Sowa ME, Tan MJ,
Jeudy S, Hayes SD, Santha S, Münger K, Harper JW, Howley PM: Systematic identification of interactions between host cell proteins and E7 oncoproteinsfrom diverse human papillomaviruses, Proc Natl Acad Sci U S A. 2012 Jan 9.
[Epub ahead of print] 167. Spangle JM, Gosh-Choudhury N, Munger K: Activation
of cap dependent translation by mucosal Human Papillomavirus E6 proteins is
dependent on the integrity of the LXXLL binding motif, J. Virol 2012, in press 168. Gulbahce N, Yan H, Dricot
A, Padi M, Byrdsong D, Franchi R, Lee D-S, Rozenblatt-Rosen O, Mar JC, Calderwood
MA, Baldwin A, Zhao B, Santhanam B, Braun P, Huh K-W, Hellner K, Grace M, Chen
A, Rubio R, Marto JA, Christakis NA, Kieff E, Roth FP, Roecklein-Canfield J,
DeCaprio JA, Cusick ME, Quackenbush J, Hill DE, Münger K, Vidal M, Barabási AL: Viral perturbations of host networks reflect
disease etiology, PLoS Comp Biol 2012, in press 169. Klionsky DJ, (…771 authors…), Munger K, (…492 authors…): Guidelines for the use and interpretation of assays for monitoring
autophagy, Autophagy 2012, 8: in press 170. McLaughlin-Drubin ME, Meyers J, Munger K:
Cancer-associated human papillomaviruses, Curr Op Virol 2012 in press
|